Flonase Spanish-Language TV Ads Disclose No Risk Info - Warning Letter
Executive Summary
Glaxo Wellcome's Spanish-language broadcast advertisement for Flonase (fluticasone) failed to disclose any warning or risk information, FDA reported in an Aug. 18 warning letter to the company.
You may also be interested in...
FDA Response Time For DTC Ad Advisory Comments Has Doubled, Agency Says
FDA has increased from two to four weeks the time it takes to return direct-to-consumer broadcast ads with advisory comments due to the enlarged volume of submissions, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, reported Sept. 13 at a Food & Drug Law Institute conference on "Marketing and Promotion in the New Millennium."
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011